Access & Prescribing (Australia & Global)
China’s National Drug Price Negotiation Improves Pediatric Medicine Affordability, But Access Gaps Remain
A new study evaluates China's National Drug Price Negotiation policy, revealing improved affordability for pediatric medicines but persistent challenges i…
Clinical Trials & Medical Research
Advancing Silicosis Research: The Potential of 3D In Vitro Models for Understanding Lung Disease
New silicosis research is exploring 3D in vitro models to better understand disease mechanisms and identify therapeutic targets. Learn how these advanced…
Access & Prescribing (Australia & Global)
Addressing Medicinal Cannabis Stigma: A Barrier to Patient Access and Informed Care
New research indicates significant medicinal cannabis stigma persists, even within the medical community. Learn how this perception impacts patient access…
Access & Prescribing (Australia & Global)
Israeli Health Ministry Panel Recommends Phasing Out Smoked Medical Cannabis
A recent panel from Israel's Health Ministry suggests phasing out smoked medical cannabis in favour of alternative delivery methods, citing health risks a…
Access & Prescribing (Australia & Global)
Telemedicine Becomes Primary Channel for Global Medical Cannabis Access Amid Regulatory Scrutiny
Explore how telemedicine has become the default route for medical cannabis access across the US, Germany, UK, and Australia, examining the drivers and eme…
Equities, Investment & Market Trends
Federal Medical Cannabis Reclassification to Schedule III Alters Financial Landscape for US Operators
The Department of Justice and DEA have reclassified medical cannabis to Schedule III. Discover how this impacts US operators, IRS Code 280E, and potential…
Global Regulatory Updates
Industrial Hemp Market Faces Regulatory Challenges as Stakeholders Seek Clearer Policy Frameworks
Industrial hemp's market potential is hindered by a definition problem. Policy solutions aim to clarify regulations for agricultural products and cannabin…
Access & Prescribing (Australia & Global)
Israel Proposes Significant Overhaul of Medical Cannabis Guidelines, Shifting Responsibility to Health Funds
Israel's Health Ministry proposes significant changes to medical cannabis guidelines, aiming to integrate treatment into health funds and enhance patient…
Equities, Investment & Market Trends
US Industrial Hemp Market Faces Policy Challenges Amidst Regulatory Ambiguity
The US industrial hemp market faces significant policy challenges, risking its economic potential. Learn how current regulations impact fiber and grain se…
Access & Prescribing (Australia & Global)
Crown Dependencies Urged to Consider Cannabis Policy Pilot Schemes for Data Collection
A campaigner advocates for Crown Dependencies to implement cannabis policy pilot schemes, focusing on public health data and regulatory insights. Learn ho…
